LONDON, GB / ACCESS Newswire / March 31, 2025 / Hemogenyx Pharmaceuticals plc (LSE:HEMO), the biopharmaceutical group developing new therapies and treatments for blood diseases, announces that the ...
Delisting agreement and announced delisting tender offer31-March-2025 / 08:40 CET/CESTDisclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by EQS ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback